ES267045A1 - New dialkyl xanthine derivatives and the preparation thereof - Google Patents

New dialkyl xanthine derivatives and the preparation thereof

Info

Publication number
ES267045A1
ES267045A1 ES0267045A ES267045A ES267045A1 ES 267045 A1 ES267045 A1 ES 267045A1 ES 0267045 A ES0267045 A ES 0267045A ES 267045 A ES267045 A ES 267045A ES 267045 A1 ES267045 A1 ES 267045A1
Authority
ES
Spain
Prior art keywords
preparation
reacted
solutions
compounds
appropriate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0267045A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aens SA Manufacture De Produit
Original Assignee
Aens SA Manufacture De Produit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aens SA Manufacture De Produit filed Critical Aens SA Manufacture De Produit
Publication of ES267045A1 publication Critical patent/ES267045A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises compounds of general formula: <FORM:0947496/C2/1> in which R1 and R2 represent alkyl radicals, X represents an alkylene radical, R3 and R3 represent hydrogen atoms or aralkyl (e.g. furfuryl) alkyl or alkenyl groups, or R3 is hydrogen and R4 is a cycloalkyl, dialkylaminoalkyl, alkoxyalkyl or heterocyclic radical, or R3 and R4 together form a heterocyclic ring which may be substituted and their acid addition salts and processes for the preparation thereof wherein (1) an appropriate 7-haloalkylxanthine is reacted with a compound HNR3R4, or (2) an appropriate 7-unsubstituted xanthine is reacted with a compound Hal.X.NR3R4, Hal being a halogen atom. Pharmaceutical compositions comprise an acceptable carrier or diluent together with the above compounds. Forms suitable for oral (tablets, capsules, solutions, suspensions), parenteral (solutions) and rectal (suppositories) administration are mentioned. The compounds stimulate the central nervous system, and have spasmolytic action on smooth muscles and a positive inotropic action on the heart. Specification 947,494 is referred to.
ES0267045A 1960-05-03 1961-05-02 New dialkyl xanthine derivatives and the preparation thereof Expired ES267045A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB15617/60A GB947496A (en) 1960-05-03 1960-05-03 New dialkyl xanthine derivatives and the preparation thereof

Publications (1)

Publication Number Publication Date
ES267045A1 true ES267045A1 (en) 1961-12-01

Family

ID=10062377

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0267045A Expired ES267045A1 (en) 1960-05-03 1961-05-02 New dialkyl xanthine derivatives and the preparation thereof

Country Status (6)

Country Link
BE (1) BE603114A (en)
DE (1) DE1246744B (en)
ES (1) ES267045A1 (en)
FR (1) FR1357M (en)
GB (1) GB947496A (en)
LU (1) LU40076A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0011399A1 (en) * 1978-11-11 1980-05-28 FISONS plc N-substituted theophyllines, processes for their preparation and pharmaceutical compositions containing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011424B (en) * 1954-04-17 1957-07-04 Chemiewerk Homburg Ag Process for the preparation of basic substituted 7-alkyl-xanthine derivatives or their salts
US2887486A (en) * 1956-10-29 1959-05-19 S E Massengill Company Theophylline derivatives

Also Published As

Publication number Publication date
LU40076A1 (en) 1961-10-30
DE1246744B (en) 1967-08-10
BE603114A (en) 1961-10-27
GB947496A (en) 1964-01-22
FR1357M (en) 1962-06-18

Similar Documents

Publication Publication Date Title
ES8400422A1 (en) Tricyclic ethers, process for their preparation and their use in pharmaceutical preparations.
EP0233793A3 (en) Decahydroquinoline derivatives, process for their preparation, intermediates for their preparation, their use as medicaments and compositions containing them
GB973361A (en) Pyrazolo-pyrimidines and process for their manufacture
ES479820A1 (en) Isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them.
ES8303355A1 (en) Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions.
GB852795A (en) Substituted furyl-thiadiazoles and a process for their production
GB989013A (en) New guanidines and process for their manufacture
ES293991A1 (en) Intermediates for and synthesis of vitamin b and related compounds
ES266788A1 (en) New derivatives of dialkyl xanthines and the preparation thereof
GB1023793A (en) The manufacture of benzodiazepine derivatives
ES8503676A1 (en) Oxazoleacetic acid derivatives, process for their production and compositions containing said derivatives.
ES267045A1 (en) New dialkyl xanthine derivatives and the preparation thereof
GB1341698A (en) 3-amino-indeno-1,2,3-a,e-phthalazines and pharmaceutical compositions thereof
DE3269533D1 (en) New quinolylacetic acid compounds and pharmaceutical compositions containing them
ES8101074A1 (en) Theophylline derivatives, process for their preparation and medicaments containing these compounds.
ES8401059A1 (en) Bicyclic phenol ethers, process for their preparation and medicines containing these compounds.
GB1002005A (en) New benzanilide derivatives
ES291187A1 (en) Substituted piperazines
GB1032377A (en) Asymmetrical pyridoxolyl disulphides and their preparation
ES8107168A1 (en) Benzylidene derivatives, their preparation and compositions containing them
GB959699A (en) New pyrimidine derivatives
ES258082A1 (en) New guanidines and process for their manufacture
GB810304A (en) Improvements in or relating to amines
GB839784A (en) Phenothiazine derivatives
GB920859A (en) Substituted triphenylmethanols